Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04368247Completed

Skin Fluorescent Imaging (SFI) System in Patients With Nevi

Role: lead

NCT06246903Unknown

INTER-PATHOLOGIST READER STUDY

Role: lead

NCT03535077Completed

Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging)

Role: lead

NCT03109327Completed

Investigating the Clinical Utility of the MDS

Role: lead

NCT02056522Completed

Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging

Role: lead

NCT02009085Completed

Pilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection.

Role: lead

NCT02193581Completed

Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging

Role: lead

All 7 trials loaded